Register your interest for the Wegovy weight loss treatment... coming soon

The first and only weekly prescription weight loss drug

It’s injected on the same day each week, at any time of day, with or without food.

What is Wegovy?

Wegovy® is a weight loss drug containing the active ingredient semglutide. It’s an injection you give yourself just once a week to help you lose weight. It is available for adults aged between 18 and 75 who:

are obese (BMI over 30)

are overweight (BMI higher than 27) and you have a weight-related health condition including asthma, cardiovascular disease,  depression, fatty liver disease, gallbladder disease, high blood pressure, osteoarthritis, gout, polycystic ovary syndrome, or sleep apnoea

You won’t be able to use Wegovy if you:

 are over 75

 are pregnant or breastfeeding

 have liver, kidney or heart failure, an eating disorder, or pancreatitis

 are taking insulin, sulphonylureas or other weight loss drugs that work in the same way as Wegovy, e.g. Victoza

Wegovy weight-management medicine is formulated to help you lose weight and maintain a healthy, sustainable weight.


How does it work?

Wegovy works by suppressing your appetite meaning you feel fuller for longer and have less cravings. The active ingredient semaglutide mimics the action of the hormone that’s involved in regulating appetite. This means you should eat less and when combined with regular activity and a balanced diet, this can help you to lose weight.


How much weight have people lost with Wegovy?

In a 68-week medical study of 1,961 adults* living with obesity, or excess weight and a related medical problem.

Medication was taken in conjunction with a reduced-calorie diet and increased physical activity.

*Source, Wegovy medical study. Results are from a 68-week medical study of adults with obesity (BMI ≥30) and adults with excess weight (BMI ≥27) who also had weight-related medical problems including high blood pressure or high cholesterol. People with type 2 diabetes were excluded. Both groups were instructed to take the medicine along with a reduced-calorie meal plan and increased physical activity. 7% of people taking Wegovy® (92 people) le the medical study due to side effects, compared to 3.1% of people taking placebo (20 people).


Decisions about treatment are for you and the prescriber to jointly consider during a consultation. However, the final decision will always be the prescriber's.

Pharmacy2U By Pharmacy2U Published 16/02/2023